Issues related to Medicare reimbursement for Part D drugs; Issues related to CY2020 End Stage Renal Disease (ERSD) Prospective Payment System; Medigap insurance access for ESRD beneficiaries; S. 1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019; H.R. 3436, Seniors' Chronic Care Management Improvements Act of 2019; H.R> 3912, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019

Administrative action to provide relief for health care providers during the COVID-19 crisis. Issues related to Medicare reimbursement for Part D drugs; Issues related to CY2020 End Stage Renal Disease (ERSD) Prospective Payment System; Medigap insurance access for ESRD beneficiaries; S. 1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019; H.R. 3436, Seniors' Chronic Care Management Improvements Act of 2019; H.R> 3912, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
MMM - Medicare/Medicaid HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE
AKEBIA THERAPEUTICS, INC.
245 First Street, Suite 1100, Cambridge, MA, 02142, US
SARA FROELICH SARA FROELICH